RVMD Live signals | Maximize Profits with Getagraph.com

BUY 1095 min ago

@ $36.36

Issued: 18 Apr 2024 @ 09:42

Return: -1.46%

Previous signal: Apr 17 - 15:54

Previous signal: Sell

Return: -2.18 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 1.08% compare to its pairs and should correct upwards.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers...

Stats
Today's Volume	851 787
Average Volume	1.44M
Market Cap	5.90B
EPS	$0 ( 2024-02-26 )
Next earnings date	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.28
ATR14	$1.340 (3.74%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Goldsmith Mark A	Sell	7 500	Common Stock
2024-04-10	Goldsmith Mark A	Sell	5 000	Common Stock
2024-04-10	Goldsmith Mark A	Sell	5 000	Common Stock
2024-04-10	Patel Sushil	Sell	2 155	Stock Option (Right to Buy)
2024-04-10	Patel Sushil	Buy	2 155	Common Stock

INSIDER POWER
73.06
Last 99 transactions
Buy: 5 403 428 \| Sell: 788 601

Correlation (AI algo v.1.1b): Undervalued: 1.08% $36.22 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.73 (moderate negative)

Short: -0.77 (moderate negative)

Signal:(23) Neutral

Revolution Medicines Inc Correlation

10 Most Positive Correlations
TBNK	0.884
RING	0.853
RGLD	0.852
DOOO	0.849
GTH	0.834
GRAB	0.834
TRUE	0.831
PWOD	0.83
MCHI	0.828
YY	0.825

10 Most Negative Correlations
LLNW	-0.82
SFET	-0.808
LNSR	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Revolution Medicines Inc Correlation - Currency/Commodity

-0.66
( moderate negative )

-0.49
( neutral )

0.00
( neutral )

0.28
( neutral )

-0.55
( weak negative )

0.12
( neutral )

Revolution Medicines Inc Financials

Annual	2023
Revenue:	$11.58M
Gross Profit:	$2.27M (19.61 %)
EPS:	$-3.86

Q3	2023
Revenue:	$742 000
Gross Profit:	$-2.12M (-285.18 %)
EPS:	$-1.140

Q2	2023
Revenue:	$0
Gross Profit:	$-2.15M (0.00 %)
EPS:	$-0.990

Q2	2023
Revenue:	$3.82M
Gross Profit:	$3.82M (100.00 %)
EPS:	$-0.920

Financial Reports:

No articles found.

Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.